Prior to joining Bio-Tissue, Andy was the National Sales Manager for OptiMedica, Inc., where he was responsible for the successful launch of the company’s pattern scanning laser technology for the treatment of retinal diseases. Previously, Andy held sales and sales management positions at several prestigious ophthalmic companies, including: Lumenis, Inc./Coherent Medical Group and Storz Ophthalmics (a division of Bausch and Lomb).
“We are excited about bringing Andy Wasserman on board as a critical member of our management team,” said Amy Tseng, President of Bio-Tissue. “Andy has a proven track record with considerable experience in the ophthalmic industry that will enhance the market penetration of Bio-Tissue’s cryopreserved amniotic membrane products. We are confident that 2009 will bring new and exciting opportunities for the growth of our company with Andy leading our sales and marketing efforts.”
About Bio-Tissue Bio-Tissue’s patented cryopreserved amniotic membrane products, AMNIOGRAFT® and PROKERA®, provide the natural healing properties of amniotic membrane to restore ocular surface function with minimal inflammation and scarring for ophthalmic indications such as pterygium, conjunctivochalasis, corneal epithelial defects, chemical burns and many more ocular surface indications. Visit www.biotissue.com to learn more.
